UPDATE: UBS Downgrades Bio-Reference Laboratories (BRLI) to Neutral; Valuation Call; Takeout Scenario Offered
Tweet Send to a Friend
(Updated - August 24, 2012 9:42 AM EDT)
UBS downgraded Bio-Reference Laboratories (NASDAQ: BRLI) from Buy to Neutral. PT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS downgraded Bio-Reference Laboratories (NASDAQ: BRLI) from Buy to Neutral. PT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
